securities fraud

Class action filed against $METC alleging executives made false statements about Brook Mine development progress. Investors who purchased securities July-October 2025 may be eligible.

Securities fraud lawsuit filed against $DRVN alleging false financial statements, weak controls, and revenue overstatement from May 2023 through February 2026.

Class action lawsuit filed against $SNOW alleging securities fraud over concealed product changes and CEO departure rumors during June 2023-February 2024 period.

Mereo BioPharma faces class action lawsuit alleging false statements about failed Phase 3 trials ORBIT and COSMIC. Investors from June 2023-December 2025 eligible; lead plaintiff deadline April 2026.

Schall Law Firm files securities fraud class action against $MNDY for allegedly misrepresenting revenue outlook and customer growth prospects.

Law firm Holzer & Holzer filed class action lawsuit against $ALIT for allegedly making false dividend statements. Multiple companies now under investigation.

Portnoy Law Firm investigates Novo Nordisk for possible securities fraud after CagriSema obesity drug failed trial, triggering 16.43% stock decline.

Rosen Law Firm files class action against $EOSE for alleged false statements on production capacity and guidance. Lead plaintiff deadline: May 5, 2026.

Glancy Prongay law firm files class action against Grocery Outlet ($GO) alleging materially false statements about financial performance and undisclosed rapid expansion problems.

Green Dot shares fell 7% after delaying Q4/2025 earnings, triggering securities investigation by Johnson Fistel examining potential disclosure violations.

Law firm seeks investors in $METC class action over claims company overstated Wyoming mine development progress, triggering 9.6% stock decline.

Rosen Law Firm files class action against Soleno Therapeutics for allegedly concealing fluid retention safety concerns in DCCR clinical trials, affecting drug viability.

Class action lawsuit filed against $ORCL alleging misleading statements about AI infrastructure strategy and capital expenditures between June-December 2025.

Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR drug safety concerns, patient death, and disappointing Q3 results.

Driven Brands faces securities fraud lawsuit after revealing three years of financial reporting errors, causing 40% stock collapse on February 25, 2026.

Soleno Therapeutics faces class action lawsuit for allegedly concealing drug safety risks including fluid retention and diabetes complications. Affected shareholders can claim losses through May 2026.

$AQST plummets 37% after FDA rejects Anaphylm application. Investors sue over alleged misleading statements about approval prospects.

Apollo Global Management faces securities fraud class action after DOJ files reveal undisclosed business dealings with Jeffrey Epstein, contradicting prior denials. Stock fell 5%.

DNOW shares fell 19.1% after missing Q4 2025 earnings expectations. The Rosen Law Firm is investigating potential securities claims on behalf of affected investors.

Faruqi & Faruqi investigates Zynex securities fraud claims over alleged revenue inflation. Investor lawsuit deadline: April 21, 2026.